18 September 2020
Kirkland Represents GTCR and Corza Health on Acquisition of TachoSil Surgical Patch from Takeda
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Jacob Traff Lead | Kirkland & Ellis | Partner | Not stated | Not stated |
| Christopher Thomas Lead | Kirkland & Ellis | Partner | Not stated | Not stated |
| Michael Weed Lead | Kirkland & Ellis | Partner | Not stated | Not stated |
| Sanford Perl Lead | Kirkland & Ellis | Partner | Not stated | Not stated |
| David Higgins Lead | Kirkland & Ellis | Partner | Not stated | Not stated |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- EUR 350m (€350 million)
- What the figure measures
- Total transaction value
- Client
- GTCR and Corza Health, Inc.Buy-side
- Counterparties
- Takeda Pharmaceutical Company Limited (Sell-side)